IPN.PA
Ipsen SA
Price:  
109.50 
EUR
Volume:  
61,373.00
France | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IPN.PA EV/EBITDA

30.6%
Upside

As of 2025-03-15, the EV/EBITDA ratio of Ipsen SA (IPN.PA) is 5.20. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IPN.PA's latest enterprise value is 9,042.29 mil EUR. IPN.PA's TTM EBITDA according to its financial statements is 1,739.30 mil EUR. Dividing these 2 quantities gives us the above IPN.PA EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 6.4x - 9.6x 7.2x
Forward P/E multiples 10.5x - 14.8x 12.6x
Fair Price 112.23 - 201.67 142.96
Upside 2.5% - 84.2% 30.6%
109.50 EUR
Stock Price
142.96 EUR
Fair Price

IPN.PA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-03-14 5.20
2025-03-13 5.20
2025-03-12 5.30
2025-03-11 5.17
2025-03-10 5.22
2025-03-07 5.22
2025-03-06 5.32
2025-03-05 5.26
2025-03-04 5.37
2025-03-03 5.34
2025-02-28 5.28
2025-02-27 5.22
2025-02-26 5.24
2025-02-25 5.39
2025-02-24 5.27
2025-02-21 5.24
2025-02-20 5.18
2025-02-19 5.23
2025-02-18 5.31
2025-02-17 5.31
2025-02-14 5.29
2025-02-13 5.36
2025-02-12 5.66
2025-02-11 5.80
2025-02-10 5.81
2025-02-07 5.78
2025-02-06 5.78
2025-02-05 5.74
2025-02-04 5.67
2025-02-03 5.68
2025-01-31 5.67
2025-01-30 5.65
2025-01-29 5.63
2025-01-28 5.64
2025-01-27 5.76
2025-01-24 5.68
2025-01-23 5.69
2025-01-22 5.62
2025-01-21 5.70
2025-01-20 5.86
2025-01-17 5.87
2025-01-16 5.94
2025-01-15 5.76
2025-01-14 5.66
2025-01-13 5.67
2025-01-10 5.64
2025-01-09 5.65
2025-01-08 5.58
2025-01-07 5.58
2025-01-06 5.53